HudsonAlpha Receives Grant To Continue Collaborative ALS Project With Crestwood

Please CLICK HERE to visit the Alabama NewsCenter website to see this article in its entirety and any other images or videos that go with the article.

By HudsonAlpha Institute for Biotechnology

The HudsonAlpha Institute for Biotechnology has been awarded a grant for $20,000 from the ALS Association to continue a collaborative clinical research project, Impacting ALS, with Huntsville’s Crestwood Medical Center.

The goal of Impacting ALS is to identify genetic variants or changes that contribute to amyotrophic lateral sclerosis. The progressive neurodegenerative disease affects nerve cells in the brain and spinal cord. As many as 20,000 Americans live with ALS and 15 new cases are diagnosed in the U.S. every day.

“Hopefully, in understanding some of the biology behind ALS, we’ll be able to understand different avenues of how this disease happens, what causes it and, eventually, be able to find targets that can be useful for therapeutics and different treatments,” said Richard Myers, HudsonAlpha president and science director, and the Loya Endowed Faculty Chair in Genomics. “We are grateful to work with Crestwood and ALS patients right here in Huntsville for this project.”

Category: ALL POSTS, Partner News Stories